French National Institute of Health and Medical Research-医療機器分野:企業M&A・提携分析

◆英語タイトル:French National Institute of Health and Medical Research - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011679
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥53,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥80,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
French National Institute of Health and Medical Research (INSERM) is a biomedical research institute that conducts research in biology, medicine and public health. The institute offers research in the therapeutic areas of neurosciences, cognitive sciences, neurology, psychiatry, cancer, immunology, inflammation, genetics, cancer, infectiology and microbiology, physiopathology, public health, health technologies, metabolism, cell biology and immunology, among others. It provides services in the areas of human diseases and research findings to the medical community, and to both national and international partners. INSERM also conducts translational research and development services. It operates research units and research centers. INSERM is headquartered in Paris, France.

French National Institute of Health and Medical Research – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
French National Institute of Health and Medical Research, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
French National Institute of Health and Medical Research, Medical Equipment Deals By Type, 2011 to YTD 2017 6
French National Institute of Health and Medical Research, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
French National Institute of Health and Medical Research, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
French National Institute of Health and Medical Research, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
French National Institute of Health and Medical Research, Medical Equipment, Deal Details 11
Partnerships 11
Advanced Biological Labs Enters into Licensing Agreement with Inserm Transfert 11
Advanced Biological Labs, Inserm Transfert and Centre Hospitalier Universitaire Enter into Licensing Agreement for PyroVir software 12
Tataa Biocenter Enters into Licensing Agreement with Inserm for ValidPrime Technology 13
IntegraGen Enters Into Licensing Agreement With Paris Descartes University For hsa-miR-31-3p 14
Qiagen Enters Into Licensing Agreement With Inserm Transfert For Colorectal Cancer Biomarker 16
Dassault Systemes Enters into Agreement with Inserm Transfert 17
Sebia Enters Into Co-Development Agreement With Institut National de la Sante And Inserm Transfert 18
Imcheck Therapeutics Enters Into Licensing Agreement with Inserm Transfert and SATT South East 19
PEP-Therapy Enters into Agreement with Inserm Transfert, Institut Curie and Pierre and Marie 20
Inserm Transfert Enters into Licensing Agreement with HalioDx 21
French National Institute of Health and Medical Research – Key Competitors 22
French National Institute of Health and Medical Research – Key Employees 23
French National Institute of Health and Medical Research – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Affiliate 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
French National Institute of Health and Medical Research, Medical Equipment, Key Facts 2
French National Institute of Health and Medical Research, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
French National Institute of Health and Medical Research, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
French National Institute of Health and Medical Research, Medical Equipment Deals By Type, 2011 to YTD 2017 6
French National Institute of Health and Medical Research, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
French National Institute of Health and Medical Research, Deals By Market, 2011 to YTD 2017 8
French National Institute of Health and Medical Research, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Advanced Biological Labs Enters into Licensing Agreement with Inserm Transfert 11
Advanced Biological Labs, Inserm Transfert and Centre Hospitalier Universitaire Enter into Licensing Agreement for PyroVir software 12
Tataa Biocenter Enters into Licensing Agreement with Inserm for ValidPrime Technology 13
IntegraGen Enters Into Licensing Agreement With Paris Descartes University For hsa-miR-31-3p 14
Qiagen Enters Into Licensing Agreement With Inserm Transfert For Colorectal Cancer Biomarker 16
Dassault Systemes Enters into Agreement with Inserm Transfert 17
Sebia Enters Into Co-Development Agreement With Institut National de la Sante And Inserm Transfert 18
Imcheck Therapeutics Enters Into Licensing Agreement with Inserm Transfert and SATT South East 19
PEP-Therapy Enters into Agreement with Inserm Transfert, Institut Curie and Pierre and Marie 20
Inserm Transfert Enters into Licensing Agreement with HalioDx 21
French National Institute of Health and Medical Research, Key Competitors 22
French National Institute of Health and Medical Research, Key Employees 23
French National Institute of Health and Medical Research, Subsidiaries 24
French National Institute of Health and Medical Research, Affiliate 24

★海外企業調査レポート[French National Institute of Health and Medical Research-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Circle K Stores Inc:企業の戦略・SWOT・財務情報
    Circle K Stores Inc - Strategy, SWOT and Corporate Finance Report Summary Circle K Stores Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Accrol Group Holdings PLC (ACRL):企業の財務・戦略的SWOT分析
    Accrol Group Holdings PLC (ACRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Mittal Investments S.a.r.l.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Mittal Investments S.a.r.l. Mer …
  • Adaptive Biotechnologies Corp:企業のM&A・提携動向(医療機器分野)
    Summary Adaptive Biotechnologies Corp (Adaptive) specializes in combining high-throughput sequencing and expert bioinformatics to profile T-cell and B-cell receptors. The company’s product portfolio comprises immunoSEQ and clonoSEQ. It provides immunosequencing platform to laboratories to conduct re …
  • DONG Energy AS (DENERG):企業のM&A・提携動向(石油・ガス分野)
    Summary Dong Energy A/S (Dong Energy) procures, produces, distributes and trades energy. It generates electricity and heat using conventional fuel and wind energy sources. The company also explores and produces oil and natural gas; stores natural gas; transports crude oil; and markets and sells natu …
  • Georgia Power Company (GPW):企業のM&A・提携動向(発電分野)
    Summary Georgia Power Company (Georgia Power), a subsidiary of the Southern Power Company, generates, transmits, distributes and sells electricity. The company supplies electricity in the state of Georgia and sells electricity to wholesale customers in the southeast region of the US. Georgia Power a …
  • Starr International Company, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Starr International Company, In …
  • Halozyme Therapeutics Inc (HALO):企業財務及び戦略的SWOT分析
    Halozyme Therapeutics Inc (HALO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Chairman’s Brand Corporation:企業概要およびSWOT分析
    Summary Canadean's "Chairman's Brand Corporation : Foodservice - Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, compa …
  • EnteroMedics Inc (ETRM):企業財務及び戦略的SWOT分析
    Summary EnteroMedics Inc (Enteromedics) is a medical device company that offers therapeutic products for gastrointestinal and metabolic diseases. The company designs and develops medical devices for the treatment of obesity and other disorders. It develops and provides VBLOC therapy used in the trea …
  • Probiotec Ltd (PBP):企業財務及び戦略的SWOT分析
    Summary Probiotec Ltd (Probiotec) is a healthcare solution provider that manufactures, markets and distributes prescription and over-the-counter pharmaceuticals, complementary medicines and specialty ingredients. The company offers weight management products, skin care products and animal nutrition …
  • Penske Automotive Group, Inc.:企業のM&A・提携・投資分析
    Penske Automotive Group, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Penske Automotive Group, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Ciena Corporation:企業の戦略・SWOT・財務分析
    Ciena Corporation - Strategy, SWOT and Corporate Finance Report Summary Ciena Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Lupin Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Lupin Limited Mergers and Acqui …
  • Lanco Infratech Ltd:発電所・企業SWOT分析
    Lanco Infratech Ltd – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • Physio-Control, Inc.:企業のM&A・提携動向(医療機器分野)
    Summary Physio-Control, Inc. (Physio-Control), a subsidiary of Bain Capital, LLC is a medical device company that offers development, manufacture, sale and service of emergency medical response products. The company offers pre-hospital, hospital, military, and accessory and disposable products. Its …
  • CDK Global, Inc. (CDK):企業の財務・戦略的SWOT分析
    CDK Global, Inc. (CDK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Central Reinsurance Corporation:企業の戦略・SWOT・財務情報
    Central Reinsurance Corporation - Strategy, SWOT and Corporate Finance Report Summary Central Reinsurance Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Salmat Limited (SLM):企業概要、財務及び戦略的SWOT分析
    Summary Salmat Limited (Salmat) is a customer communication solution provider. The company provides a complete range of integrated channel communication products and services to support its clients to find, acquire, grow and retain customers. It offers services such as mobile marketing, data solutio …
  • RedHill Biopharma Ltd. (RDHL):企業概要、財務及び戦略的SWOT分析
    Summary RedHill Biopharma Ltd. (RedHill) is a biopharmaceutical company. It intends to acquire and develop late clinical-stage, proprietary drugs for the treatment of gastrointestinal and inflammatory conditions. The company’s product pipeline includes RP101, a proprietary, first-in-class, heat shoc …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆